propionylcarnitine has been researched along with Peripheral Vascular Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andreozzi, GM | 1 |
| Acerra, G; del Guercio, R; Fasano, C; Federico, P; Gioia, F; Madrid, E; Mattera, E; Ragozzino, G; Salomone, P | 1 |
| Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Massimiliano, A; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS | 1 |
| Anzaldi, M; Celotta, G; Di Pino, L; Fallico, R; Fatuzzo, P; Ferrante, M; Neri, S; Oliveri Conti, G; Pennisi, G; Rapisarda, F; Signorelli, SS | 1 |
| Albano, O; Antonica, G; Berardi, E; Brevetti, G; Buonamico, P; Ferraioli, G; Godi, L; Sabbá, C | 1 |
| Arrigoni Martelli, E; Aureli, T; Conti, F; Corsico, N; Di Cocco, ME; Lucreziotti, MR; Miccheli, A; Nardone, A; Pesce, D; Spagnoli, LG | 1 |
| Amato, B; Aprea, G; Cerfolio, P; Markabaoui, AK; Persico, G | 1 |
| Azzena, G; Cittanti, C; Colamussi, P; Giganti, M; Manfrini, S; Orlandi, C; Piffanelli, A; Uccelli, L | 1 |
| Aureli, T; Capuani, G; Cavallaro, A; Conti, F; Di Marzo, L; Giuliani, A; Miccheli, A; Mingoli, A; Sapienza, P; Tedesco, M | 1 |
| Askew, CD; Barker, GA; Green, AA; Green, S; Walker, PJ | 1 |
| Angelini, C; Brevetti, G; Carrozzo, R; Corsi, M; Marcialis, A; Matarazzo, A; Perna, S; Rosa, M | 1 |
1 review(s) available for propionylcarnitine and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Propionyl l-carnitine: intermittent claudication and peripheral arterial disease.
Topics: Cardiotonic Agents; Carnitine; Exercise; Humans; Intermittent Claudication; Peripheral Vascular Diseases | 2009 |
8 trial(s) available for propionylcarnitine and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Effects of propionyl-carnitine in patients with type 2 diabetes and peripheral vascular disease: results of a pilot trial.
Topics: Blood Glucose; Carnitine; Diabetes Mellitus, Type 2; Female; Humans; Injections, Intravenous; Male; Middle Aged; Peripheral Vascular Diseases; Pilot Projects; Treatment Outcome; Vasodilator Agents | 2004 |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis.
Topics: Aged; Aldehydes; Carnitine; Double-Blind Method; Humans; Malondialdehyde; Middle Aged; Nitrates; Nitrites; Oxygen; Peripheral Vascular Diseases; Placebos; Renal Dialysis; Renal Insufficiency | 2006 |
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease.
Topics: Ankle; Branchial Region; Carnitine; Double-Blind Method; Endothelin-1; Homocysteine; Humans; Infusions, Intravenous; Kidney Failure, Chronic; Peripheral Vascular Diseases; Placebos; Renal Dialysis | 2006 |
Comparison between the effect of L-propionylcarnitine, L-acetylcarnitine and nitroglycerin in chronic peripheral arterial disease: a haemodynamic double blind echo-Doppler study.
Topics: Acetylcarnitine; Blood Flow Velocity; Cardiotonic Agents; Carnitine; Child, Preschool; Cross-Over Studies; Double-Blind Method; Femoral Artery; Hemodynamics; Humans; Male; Middle Aged; Nitroglycerin; Peripheral Vascular Diseases; Ultrasonography, Doppler, Pulsed | 1994 |
The early effects of intravenous L-propionyl carnitine on ulcerative trophic lesions of the lower limbs in arteriopathic patients: a controlled randomized study.
Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Arterial Occlusive Diseases; Blood Coagulation; Carnitine; Female; Humans; Infusions, Intravenous; Ketoprofen; Leg Ulcer; Male; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow | 1995 |
Technetium-99m sestamibi leg scintigraphy for non-invasive assessment of propionyl-L-carnitine induced changes in skeletal muscle metabolism.
Topics: Arterial Occlusive Diseases; Carnitine; Female; Humans; Leg; Male; Middle Aged; Muscle, Skeletal; Peripheral Vascular Diseases; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ultrasonography, Doppler | 1997 |
31Phosphorus magnetic resonance spectroscopy to evaluate medical therapy efficacy in peripheral arterial disease. A pilot study.
Topics: Aged; Animals; Carnitine; Double-Blind Method; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Peripheral Vascular Diseases; Phosphorus | 1999 |
Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Carnitine; Exercise; Female; Humans; Intermittent Claudication; Male; Middle Aged; Muscle, Skeletal; Peripheral Vascular Diseases; Physical Endurance; Single-Blind Method; Treatment Outcome; Walking | 2001 |
2 other study(ies) available for propionylcarnitine and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Effect of propionyl-L-carnitine in a rat model of peripheral arteriopathy: a functional, histologic, and NMR spectroscopic study.
Topics: Animals; Cardiotonic Agents; Carnitine; Disease Models, Animal; Energy Metabolism; Femoral Artery; Hindlimb; Magnetic Resonance Spectroscopy; Male; Muscles; Peripheral Vascular Diseases; Rats; Rats, Wistar | 1993 |
Muscle carnitine deficiency in patients with severe peripheral vascular disease.
Topics: Aged; Carnitine; Carnitine O-Acetyltransferase; Carnitine O-Palmitoyltransferase; Humans; Ischemia; Middle Aged; Muscles; Peripheral Vascular Diseases | 1991 |